Jingqi Hu, Hailiang Tang, Ming Xu, Jian Xu, Ping Zhong
{"title":"Microsurgery of a rare case of abducens schwannoma: surgical techniques.","authors":"Jingqi Hu, Hailiang Tang, Ming Xu, Jian Xu, Ping Zhong","doi":"10.21037/cco-2025-aw-126","DOIUrl":null,"url":null,"abstract":"<p><p>Abducens schwannoma is relatively very rare, and accounts for only about 1% of all intracranial schwannomas. Here, we report microsurgical resection of a rare case of cisternal-segment abducens schwannoma in a female patient. Upon physical examination, the patient showed no eye movement symptoms, and facial & auditory nerves function were normal, but showed slight unsteady walking and positive Romberg sign. Magnetic resonance imaging (MRI) scan of the brain revealed a mass located at the right cerebellopontine angle (CPA), and the tumor was partially enhanced after contrast MRI scan. Thus, schwannoma is suspected before surgery, but it's difficult to identify its origin by MRI images. Considering tumor compression to brain stem and available microsurgical techniques nowadays, we selected craniotomy surgery for the patient, and classic retro-sigmoid approach was recommended, which is a safe and commonly used surgical approach. During the surgery, the tumor was found to arise from the abducens nerve, and a total resection of the schwannoma was finally achieved under intra-operative neuro-monitoring. The patient tolerated the surgery very well, but had transient abducens paralysis and ataxia after surgery, and gradually improved in 3 months. The follow-up brain MRI images 3 months after surgery indicated no residual or relapse of the tumor.</p>","PeriodicalId":9945,"journal":{"name":"Chinese clinical oncology","volume":"15 1","pages":"5"},"PeriodicalIF":2.7000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/cco-2025-aw-126","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Abducens schwannoma is relatively very rare, and accounts for only about 1% of all intracranial schwannomas. Here, we report microsurgical resection of a rare case of cisternal-segment abducens schwannoma in a female patient. Upon physical examination, the patient showed no eye movement symptoms, and facial & auditory nerves function were normal, but showed slight unsteady walking and positive Romberg sign. Magnetic resonance imaging (MRI) scan of the brain revealed a mass located at the right cerebellopontine angle (CPA), and the tumor was partially enhanced after contrast MRI scan. Thus, schwannoma is suspected before surgery, but it's difficult to identify its origin by MRI images. Considering tumor compression to brain stem and available microsurgical techniques nowadays, we selected craniotomy surgery for the patient, and classic retro-sigmoid approach was recommended, which is a safe and commonly used surgical approach. During the surgery, the tumor was found to arise from the abducens nerve, and a total resection of the schwannoma was finally achieved under intra-operative neuro-monitoring. The patient tolerated the surgery very well, but had transient abducens paralysis and ataxia after surgery, and gradually improved in 3 months. The follow-up brain MRI images 3 months after surgery indicated no residual or relapse of the tumor.
期刊介绍:
The Chinese Clinical Oncology (Print ISSN 2304-3865; Online ISSN 2304-3873; Chin Clin Oncol; CCO) publishes articles that describe new findings in the field of oncology, and provides current and practical information on diagnosis, prevention and clinical investigations of cancer. Specific areas of interest include, but are not limited to: multimodality therapy, biomarkers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to cancer. The aim of the Journal is to provide a forum for the dissemination of original research articles as well as review articles in all areas related to cancer. It is an international, peer-reviewed journal with a focus on cutting-edge findings in this rapidly changing field. To that end, Chin Clin Oncol is dedicated to translating the latest research developments into best multimodality practice. The journal features a distinguished editorial board, which brings together a team of highly experienced specialists in cancer treatment and research. The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of cancer subjects.